Detalles de la búsqueda
1.
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.
JAMA Oncol
; 1(4): 448-54, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26181252
2.
ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors.
Cancer Res
; 69(21): 8491-8, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19843847
Resultados
1 -
2
de 2
1
Próxima >
>>